Polyphenols Modulate Alzheimer’s Amyloid Beta Aggregation in a Structure-Dependent Manner
Abstract
:1. Introduction
2. Materials and Methods
2.1. Materials
2.2. Preparation of Amyloid Beta
2.3. Preparation of Polyphenol Solutions
2.4. Incubation of Amyloid Beta with and without Polyphenols
2.5. Amyloid Beta Aggregation Kinetics Using Thioflavin-T Assay
2.6. Morphological Observation Using Atomic Force Microscopy
2.7. Characterization of Redox Activity of Polyphenols
3. Results and Discussion
3.1. Polyphenol-Modulated Amyloid Beta Aggregation
3.2. Morphologies of Amyloid Beta Self-Assembly in the Presence of Polyphenols
3.3. Redox Activity of Polyphenols in the Presence of Amyloid Beta
3.4. Modulation of Amyloid Beta Aggregation by Stilbenes and Flavonoids
4. Conclusions
Supplementary Materials
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Pérez-Jiménez, J.; Neveu, V.; Vos, F.; Scalbert, A. Systematic analysis of the content of 502 Polyphenols in 452 foods and beverages: An application of the phenol-explorer database. J. Agric. Food Chem. 2010, 58, 4959–4969. [Google Scholar] [CrossRef] [PubMed]
- Ignat, I.; Volf, I.; Popa, V.I. A critical review of methods for characterisation of polyphenolic compounds in fruits and vegetables. Food Chem. 2011, 126, 1821–1835. [Google Scholar] [CrossRef] [PubMed]
- Pandey, K.B.; Rizvi, S.I. Plant polyphenols as dietary antioxidants in human health and disease. Oxid. Med. Cell. Longev. 2009, 2, 270–278. [Google Scholar] [CrossRef]
- Cieślik, E.; Grȩda, A.; Adamus, W. Contents of polyphenols in fruit and vegetables. Food Chem. 2006, 94, 135–142. [Google Scholar] [CrossRef]
- Royer, M.; Diouf, P.N.; Stevanovic, T. Polyphenol contents and radical scavenging capacities of red maple (Acer rubrum L.) extracts. Food Chem. Toxicol. 2011, 49, 2180–2188. [Google Scholar] [CrossRef] [PubMed]
- Mira, L.; Fernandez, M.T.; Santos, M.; Rocha, R.; Florêncio, M.H.; Jennings, K.R. Interactions of flavonoids with iron and copper ions: A mechanism for their antioxidant activity. Free Radic. Res. 2002, 36, 1199–1208. [Google Scholar] [CrossRef]
- Morel, I.; Lescoat, G.; Cillard, P.; Cillard, J. Role of flavonoids and iron chelation in antioxidant action. Methods Enzymol. 1994, 234, 437–443. [Google Scholar]
- Ghosh, D.; McGhie, T.K.; Zhang, J.; Adaim, A.; Skinner, M. Effects of anthocyanins and other phenolics of boysenberry and blackcurrant as inhibitors of oxidative stress and damage to cellular DNA in SH-SY5Y and HL-60 cells. J. Sci. Food Agric. 2006, 86, 678–686. [Google Scholar] [CrossRef]
- Hirvonen, T.; Virtamo, J.; Korhonen, P.; Albanes, D.; Pietinen, P. Intake of flavonoids, carotenoids, Vitamins C and E, and risk of stroke in male smokers. Stroke 2000, 31, 2301–2306. [Google Scholar] [CrossRef]
- Harborne, J.B.; Williams, C.A. Advances in flavonoid research since 1992. Phytochemistry 2000, 55, 481–504. [Google Scholar] [CrossRef]
- Candiracci, M.; Piatti, E.; Dominguez-Barragán, M.; García-Antrás, D.; Morgado, B.; Ruano, D.; Gutiérrez, J.F.; Parrado, J.; Castaño, A. Anti-inflammatory activity of a honey flavonoid extract on lipopolysaccharide-activated N13 microglial cells. J. Agric. Food Chem. 2012, 60, 12304–12311. [Google Scholar] [CrossRef] [PubMed]
- Cheng, Y.-C.; Sheen, J.-M.; Hu, W.L.; Hung, Y.-C. Polyphenols and Oxidative Stress in Atherosclerosis-Related Ischemic Heart Disease and Stroke. Oxid. Med. Cell. Longev. 2017. [Google Scholar] [CrossRef]
- Ebrahimi, A.; Schluesener, H. Natural polyphenols against neurodegenerative disorders: Potentials and pitfalls. Ageing Res. Rev. 2012, 11, 329–345. [Google Scholar] [CrossRef] [PubMed]
- Zhou, Y.; Zheng, J.; Li, Y.; Xu, D.P.; Li, S.; Chen, Y.M.; Li, H. Bin Natural polyphenols for prevention and treatment of cancer. Nutrients 2016, 8. [Google Scholar] [CrossRef]
- Blennow, K.; de Leon, M.J.; Zetterberg, H. Alzheimer’s disease. Lancet 2006, 368, 387–403. [Google Scholar] [CrossRef]
- Karran, E.; Mercken, M.; Strooper, B. De The amyloid cascade hypothesis for Alzheimer’s disease: An appraisal for the development of therapeutics. Nat. Rev. Drug Discov. 2011, 10, 698–712. [Google Scholar] [CrossRef] [PubMed]
- Serpell, L.C. Alzheimer’s amyloid fibrils: Structure and assembly. Biochim. Biophys. Acta Mol. Basis Dis. 2000, 1502, 16–30. [Google Scholar] [CrossRef]
- Mattson, M.P. Pathways towards and away from Alzheimer’s disease. Nature 2004, 430, 631–639. [Google Scholar] [CrossRef] [PubMed]
- Zhao, L.N.; Long, H.; Mu, Y.; Chew, L.Y. The toxicity of amyloid β oligomers. Int. J. Mol. Sci. 2012, 13, 7303–7327. [Google Scholar] [CrossRef]
- Velander, P.; Wu, L.; Henderson, F.; Zhang, S.; Bevan, D.R.; Xu, B. Natural product-based amyloid inhibitors. Biochem. Pharmacol. 2017, 139, 40–55. [Google Scholar] [CrossRef] [Green Version]
- Ono, K.; Yoshiike, Y.; Takashima, A.; Hasegawa, K.; Naiki, H.; Yamada, M. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: Implications for the prevention and therapeutics of Alzheimer’s disease. J. Neurochem. 2003, 87, 172–181. [Google Scholar] [CrossRef]
- Korshavn, K.J.; Jang, M.; Kwak, Y.J.; Kochi, A.; Vertuani, S.; Bhunia, A.; Manfredini, S.; Ramamoorthy, A.; Lim, M.H. Reactivity of Metal-Free and Metal-Associated Amyloid-β with Glycosylated Polyphenols and Their Esterified Derivatives. Sci. Rep. 2015, 5, 17842. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ono, K.; Hasegawa, K.; Naiki, H.; Yamada, M. Curcumin Has Potent Anti-Amyloidogenic Effects for Alzheimer’s β-Amyloid Fibrils In Vitro. J. Neurosci. Res. 2004, 75, 742–750. [Google Scholar] [CrossRef]
- Ono, K.; Hasegawa, K.; Naiki, H.; Yamada, M. Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer’s β-amyloid fibrils in vitro. Biochim. Biophys. Acta Mol. Basis Dis. 2004, 1690, 193–202. [Google Scholar] [CrossRef] [PubMed]
- Palhano, F.L.; Lee, J.; Grimster, N.P.; Kelly, J.W. Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils. J. Am. Chem. Soc. 2013, 135, 7503–7510. [Google Scholar] [CrossRef] [PubMed]
- Rivière, C.; Richard, T.; Quentin, L.; Krisa, S.; Mérillon, J.M.; Monti, J.P. Inhibitory activity of stilbenes on Alzheimer’s β-amyloid fibrils in vitro. Bioorganic Med. Chem. 2007, 15, 1160–1167. [Google Scholar] [CrossRef] [PubMed]
- Garcia-Alloza, M.; Borrelli, L.A.; Rozkalne, A.; Hyman, B.T.; Bacskai, B.J. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J. Neurochem. 2007, 102, 1095–1104. [Google Scholar] [CrossRef] [PubMed]
- Karuppagounder, S.S.; Pinto, J.T.; Xu, H.; Chen, H.L.; Beal, M.F.; Gibson, G.E. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer’s disease. Neurochem. Int. 2009, 54, 111–118. [Google Scholar] [CrossRef] [PubMed]
- Rezai-Zadeh, K.; Arendash, G.W.; Hou, H.; Fernandez, F.; Jensen, M.; Runfeldt, M.; Shytle, R.D.; Tan, J. Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res. 2008, 1214, 177–187. [Google Scholar] [CrossRef] [PubMed]
- Xie, L.; Guo, Y.; Cai, B.; Yang, J. Epimerization of epigallocatechin gallate to gallocatechin gallate and its anti-diabetic activity. Med. Chem. Res. 2013, 22, 3372–3378. [Google Scholar] [CrossRef]
- Grelle, G.; Otto, A.; Lorenz, M.; Frank, R.F.; Wanker, E.E.; Bieschke, J. Black tea theaflavins inhibit formation of toxic amyloid-β and α-synuclein fibrils. Biochemistry 2011, 50, 10624–10636. [Google Scholar] [CrossRef] [PubMed]
- Vestergaard, M.; Kerman, K. Analytical Tools for Detecting Amyloid Beta Oligomerisation and Assembly. Curr. Pharm. Anal. 2009, 5, 229–245. [Google Scholar] [CrossRef]
- Phan, H.T.T.; Shimokawa, N.; Sharma, N.; Takagi, M.; Vestergaard, M.C. Strikingly different effects of cholesterol and 7-ketocholesterol on lipid bilayer-mediated aggregation of amyloid beta (1-42). Biochem. Biophys. Rep. 2018, 14, 98–103. [Google Scholar] [CrossRef] [PubMed]
- Vestergaard, M.; Kerman, K.; Tamiya, E. An electrochemical approach for detecting copper-chelating properties of flavonoids using disposable pencil graphite electrodes: Possible implications in copper-mediated illnesses. Anal. Chim. Acta 2005, 538, 273–281. [Google Scholar] [CrossRef]
- Vestergaard, M.; Kerman, K.; Saito, M.; Nagatani, N.; Takamura, Y.; Tamiya, E.; Vestergaard, M.; Kerman, K.; Saito, M.; Nagatani, N.; et al. Communication A Rapid Label-Free Electrochemical Detection and Kinetic Study of Alzheimer’s Amyloid Beta Aggregation. J. Am. Chem. Soc. 2005, 127, 11892–11893. [Google Scholar] [CrossRef]
- Biancalana, M.; Koide, S. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim. Biophys. Acta Proteins Proteomics 2010, 1804, 1405–1412. [Google Scholar] [CrossRef]
- Morita, M.; Hamada, T.; Tendo, Y.; Hata, T.; Vestergaard, M.C.; Takagi, M. Selective localization of Alzheimer’s amyloid beta in membrane lateral compartments. Soft Matter 2012, 2012, 2816–2819. [Google Scholar] [CrossRef]
- Jiao, Y.; Yang, P. Mechanism of copper(II) inhibiting Alzheimer’s amyloid beta-peptide from aggregation: A molecular dynamics investigation. J. Phys. Chem. B 2007, 111, 7646–7655. [Google Scholar] [CrossRef] [PubMed]
- Mold, M.; Ouro-Gnao, L.; Wieckowski, B.M.; Exley, C. Copper prevents amyloid-β1-42from forming amyloid fibrils under near-physiological conditions in vitro. Sci. Rep. 2013, 3, 1256. [Google Scholar] [CrossRef] [PubMed]
- Ehrnhoefer, D.E.; Bieschke, J.; Boeddrich, A.; Herbst, M.; Masino, L.; Lurz, R.; Engemann, S.; Pastore, A.; Wanker, E.E. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol. 2008, 15, 558–566. [Google Scholar] [CrossRef]
- Suprun, E.V.; Khmeleva, S.A.; Radko, S.P.; Kozin, S.A.; Archakov, A.I.; Shumyantseva, V.V. Direct electrochemical oxidation of amyloid-β peptides via tyrosine, histidine, and methionine residues. Electrochem. Commun. 2016, 65, 53–56. [Google Scholar] [CrossRef]
- Corduneanu, O.; Janeiro, P.; Brett, A.M.O. On the electrochemical oxidation of resveratrol. Electroanalysis 2006, 18, 757–762. [Google Scholar] [CrossRef]
- Wu, Y.; Li, W.; Xu, Y.; Jin, E.; Tu, Y. Evaluation of the antioxidant effects of four main theaflavin derivatives through chemiluminescence and DNA damage analyses. J. Zhejiang Univ. Sci. B 2011, 12, 744–751. [Google Scholar] [CrossRef] [PubMed]
- Bieschke, J.; Russ, J.; Friedrich, R.P.; Ehrnhoefer, D.E.; Wobst, H.; Neugebauer, K.; Wanker, E.E. EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity. Proc. Natl. Acad. Sci. USA 2010, 107, 7710–7715. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Feng, Y.; Wang, X.P.; Yang, S.G.; Wang, Y.J.; Zhang, X.; Du, X.T.; Sun, X.X.; Zhao, M.; Huang, L.; Liu, R.T. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. Neurotoxicology 2009, 30, 986–995. [Google Scholar] [CrossRef]
- Ladiwala, A.R.A.; Lin, J.C.; Bale, S.S.; Marcelino-Cruz, A.M.; Bhattacharya, M.; Dordick, J.S.; Tessier, P.M. Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Aβ into off-pathway conformers. J. Biol. Chem. 2010, 285, 24228–24237. [Google Scholar] [CrossRef] [PubMed]
- Mousseau, N.; Derreumaux, P. Exploring the early steps of amyloid peptide aggregation by computers. Acc. Chem. Res. 2005, 38, 885–891. [Google Scholar] [CrossRef] [PubMed]
Compounds | Peak Potentials (V) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 h | 12 h | 24 h | ||||||||||||
1 | 2 | 3 | 4 | 5 | 6 | 7 | 1 | 2 | 3 | 4 | 1 | 2 | 3 | |
GCG | 0.1 | 0.59 | 0.11 | 0.6 | 0.13 | |||||||||
TF | −0.16 | 0.25 | 0.5 | 0.57 | 0.72 | 1.05 | −0.18 | 0.24 | 0.56 | −0.19 | 0.23 | 0.54 | ||
Resveratrol | 0.22 | 0.39 | 0.69 | −0.25 | 0.35 | 0.7 | −0.21 | 0.31 | 0.67 | |||||
Piceid | 0.29 | 0.7 | 0.21 | 0.31 | 0.7 | 0.28 | 0.69 | |||||||
Aβ_42 | 0.71 |
Polyphenols | Potentials (V) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
0 h | 12 h | 24 h | ||||||||||
1 | 2 | 3 | 4 | 1 | 2 | 3 | 4 | 1 | 2 | 3 | 4 | |
GCG | 0.14 | 0.67 | 0.11 | 0.11 | ||||||||
TF | −0.18 | 0.63 | 1.07 | −0.18 | 0.23 | 0.66 | 0.23 | 0.49 | ||||
Resveratrol | 0.45 | 0.66 | 0.34 | 0.71 | 0.35 | |||||||
Piceid | 0.43 | 0.73 | 0.22 | 0.31 | 0.7 | 0.27 | 0.69 |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Phan, H.T.T.; Samarat, K.; Takamura, Y.; Azo-Oussou, A.F.; Nakazono, Y.; Vestergaard, M.C. Polyphenols Modulate Alzheimer’s Amyloid Beta Aggregation in a Structure-Dependent Manner. Nutrients 2019, 11, 756. https://doi.org/10.3390/nu11040756
Phan HTT, Samarat K, Takamura Y, Azo-Oussou AF, Nakazono Y, Vestergaard MC. Polyphenols Modulate Alzheimer’s Amyloid Beta Aggregation in a Structure-Dependent Manner. Nutrients. 2019; 11(4):756. https://doi.org/10.3390/nu11040756
Chicago/Turabian StylePhan, Huong T. T., Kaouthar Samarat, Yuzuru Takamura, Auriane F. Azo-Oussou, Yasutaka Nakazono, and Mun’delanji C. Vestergaard. 2019. "Polyphenols Modulate Alzheimer’s Amyloid Beta Aggregation in a Structure-Dependent Manner" Nutrients 11, no. 4: 756. https://doi.org/10.3390/nu11040756
APA StylePhan, H. T. T., Samarat, K., Takamura, Y., Azo-Oussou, A. F., Nakazono, Y., & Vestergaard, M. C. (2019). Polyphenols Modulate Alzheimer’s Amyloid Beta Aggregation in a Structure-Dependent Manner. Nutrients, 11(4), 756. https://doi.org/10.3390/nu11040756